Lawson H, Holt-Martyn J, Dembitz V, Kabayama Y, Wang L, Bellani A
Nat Cancer. 2024; 5(6):916-937.
PMID: 38637657
PMC: 11208159.
DOI: 10.1038/s43018-024-00761-w.
Fei M, Wang Y, Chang B, Xue K, Dong F, Huang D
Blood. 2023; 142(10):903-917.
PMID: 37319434
PMC: 10644073.
DOI: 10.1182/blood.2022019537.
Janizek J, Dincer A, Celik S, Chen H, Chen W, Naxerova K
Nat Biomed Eng. 2023; 7(6):811-829.
PMID: 37127711
PMC: 11149694.
DOI: 10.1038/s41551-023-01034-0.
Subramani A, Hite M, Garcia S, Maxwell J, Kondee H, Millican G
J Cell Sci. 2023; 136(1).
PMID: 36594555
PMC: 10112972.
DOI: 10.1242/jcs.260529.
Pignatti E, du Toit T, Fluck C
Rev Endocr Metab Disord. 2022; 24(1):5-21.
PMID: 36255414
PMC: 9884658.
DOI: 10.1007/s11154-022-09756-3.
PDGFRβ cells play a dual role as hematopoietic precursors and niche cells during mouse ontogeny.
Sa da Bandeira D, Kilpatrick A, Marques M, Gomez-Salazar M, Ventura T, Gonzalez Z
Cell Rep. 2022; 40(3):111114.
PMID: 35858557
PMC: 9638014.
DOI: 10.1016/j.celrep.2022.111114.
Intrinsic function of the peptidylarginine deiminase PADI4 is dispensable for normal haematopoiesis.
Young C, Russell J, van de Lagemaat L, Lawson H, Mapperley C, Kranc K
Biol Open. 2022; 11(6).
PMID: 35603697
PMC: 9212077.
DOI: 10.1242/bio.059143.
CITED2 coordinates key hematopoietic regulatory pathways to maintain the HSC pool in both steady-state hematopoiesis and transplantation.
Lawson H, van de Lagemaat L, Barile M, Tavosanis A, Durko J, Villacreces A
Stem Cell Reports. 2021; 16(11):2784-2797.
PMID: 34715054
PMC: 8581166.
DOI: 10.1016/j.stemcr.2021.10.001.
CITED2 inhibits STAT1-IRF1 signaling and atherogenesis.
Zafar A, Ng H, Diamond-Zaluski R, Kim G, Chan E, Dunwoodie S
FASEB J. 2021; 35(9):e21833.
PMID: 34365659
PMC: 8607356.
DOI: 10.1096/fj.202100792R.
Evidence for additive and synergistic action of mammalian enhancers during cell fate determination.
Choi J, Lysakovskaia K, Stik G, Demel C, Soding J, Tian T
Elife. 2021; 10.
PMID: 33770473
PMC: 8004103.
DOI: 10.7554/eLife.65381.
JMJD6 promotes self-renewal and regenerative capacity of hematopoietic stem cells.
Lawson H, Sepulveda C, van de Lagemaat L, Durko J, Barile M, Tavosanis A
Blood Adv. 2021; 5(3):889-899.
PMID: 33560400
PMC: 7876897.
DOI: 10.1182/bloodadvances.2020002702.
Stepwise cell fate decision pathways during osteoclastogenesis at single-cell resolution.
Tsukasaki M, Huynh N, Okamoto K, Muro R, Terashima A, Kurikawa Y
Nat Metab. 2020; 2(12):1382-1390.
PMID: 33288951
DOI: 10.1038/s42255-020-00318-y.
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function.
Mapperley C, van de Lagemaat L, Lawson H, Tavosanis A, Paris J, Campos J
J Exp Med. 2020; 218(3).
PMID: 33156926
PMC: 7653684.
DOI: 10.1084/jem.20200829.
Role of CITED2 in stem cells and cancer.
An B, Ji X, Gong Y
Oncol Lett. 2020; 20(4):107.
PMID: 32831926
PMC: 7439111.
DOI: 10.3892/ol.2020.11968.
CITED2 and the modulation of the hypoxic response in cancer.
Fernandes M, Calado S, Mendes-Silva L, Braganca J
World J Clin Oncol. 2020; 11(5):260-274.
PMID: 32728529
PMC: 7360518.
DOI: 10.5306/wjco.v11.i5.260.
Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia.
Menendez-Gonzalez J, Vukovic M, Abdelfattah A, Saleh L, Almotiri A, Thomas L
Stem Cell Reports. 2019; 13(2):291-306.
PMID: 31378673
PMC: 6700503.
DOI: 10.1016/j.stemcr.2019.07.005.
Cited2 regulates proliferation and survival in young and old mouse cardiac stem cells.
Wu Q, Liu Q, Zhan J, Wang Q, Zhang D, He S
BMC Mol Cell Biol. 2019; 20(1):25.
PMID: 31315556
PMC: 6637580.
DOI: 10.1186/s12860-019-0207-2.
Hypoxia Signaling Pathway in Stem Cell Regulation: Good and Evil.
Huang X, Trinh T, Aljoufi A, Broxmeyer H
Curr Stem Cell Rep. 2019; 4(2):149-157.
PMID: 31275803
PMC: 6605067.
DOI: 10.1007/s40778-018-0127-7.
Targeting the RNA mA Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia.
Paris J, Morgan M, Campos J, Spencer G, Shmakova A, Ivanova I
Cell Stem Cell. 2019; 25(1):137-148.e6.
PMID: 31031138
PMC: 6617387.
DOI: 10.1016/j.stem.2019.03.021.
Ex vivo human HSC expansion requires coordination of cellular reprogramming with mitochondrial remodeling and p53 activation.
Papa L, Zimran E, Djedaini M, Ge Y, Ozbek U, Sebra R
Blood Adv. 2018; 2(20):2766-2779.
PMID: 30348672
PMC: 6199653.
DOI: 10.1182/bloodadvances.2018024273.